New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

OBJECTIVE. The antidiabetic properties of metformin are mediated through its ability to activate the AMP-activated protein kinase (AMPK). Activation of AMP